For example, in murine model of diabetes, activation of PPARγ by nitro-FAs restored insulin sensitivity and blood glucose levels [96] and in experimental models of COPD, treatment with PPARγ agonists contrasted cigarette smoke-induced inflammation and downregulation of HDAC2 [93, 102, 103]. Here, PPARG is linked to chronic obstructive pulmonary disease.